Aloperine Alleviates Myocardial Injury Induced by Myocardial Ischemia and Reperfusion by Activating the ERK1/2/ β-catenin Signaling Pathway

ConclusionsThese data support the cardioprotective effect of aloperine against myocardial I/R injury, which is mediated, at least in part, by the ERK1/2/ β-catenin signaling pathway.
Source: Cardiovascular Drugs and Therapy - Category: Cardiology Source Type: research